Forecyte Bio is a CDMO founded in 2021 to service the rapidly growing CGT industry. Built on decades of experience and expertise from its core technical team on CGT CMC processes, Forecyte Bio offers a 4x4TM holistic service package to accelerate clients? projects, covering 4 technology platforms (Plasmid, Viral Vector, Cell Product, and mRNA) at 4 developmental stages (R&D, Process and Assay Development, GMP, and regulatory filing). Our GMP capacities are available from both Frederick MD and Shanghai China sites. Our Viral Vector portfolio includes AAV, adenovirus, Lentivirus, Retrovirus, and oncolytic viral vector. Forecyte Bio is here to support and accelerate your CGT programs with Quality, Speed, and Agility.